Effect of RANKL Inhibition on UV-induced Immunosuppression

Clinical trial NCT01978483 · COMPLETED

Trial details

NCT number: NCT01978483
Sponsor: Innovaderm Research Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ultraviolet Rays Immunosuppression Hypersensitivity, Delayed Immune Tolerance/Drug Effects

Start date: 2013-11-01
Primary completion: 2014-06-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.